Insider Transactions in Q2 2021 at Anavex Life Sciences Corp. (AVXL)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 29
2021
|
Sandra Boenisch PFO & Treasurer |
SELL
Open market or private sale
|
Direct |
166,696
-87.89%
|
$4,334,096
$26.53 P/Share
|
|
Jun 29
2021
|
Sandra Boenisch PFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
166,696
+30.22%
|
$666,784
$4.96 P/Share
|
|
Jun 29
2021
|
Christopher U Missling President and CEO |
SELL
Open market or private sale
|
Direct |
51,620
-4.83%
|
$1,342,120
$26.0 P/Share
|
|
Jun 29
2021
|
Christopher U Missling President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
51,620
+4.6%
|
$51,620
$1.32 P/Share
|
|
May 21
2021
|
Elliot Favus Director |
SELL
Open market or private sale
|
Direct |
145,000
-100.0%
|
$1,595,000
$11.7 P/Share
|
|
May 21
2021
|
Elliot Favus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
145,000
+15.0%
|
$580,000
$4.12 P/Share
|
|
May 17
2021
|
Peter D.O. Donhauser Director |
BUY
Open market or private purchase
|
Direct |
1,000
+31.6%
|
$10,000
$10.93 P/Share
|